(Press-News.org) Embargoed for release until 5:00 p.m. ET on Monday 1 September 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. Personalized risk messages fail to boost colorectal cancer screening participation
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-24-03144
URL goes live when the embargo lifts
A randomized controlled trial aimed to determine whether providing information on patient risk for advanced colorectal neoplasia (ACN) to patients and providers affects colorectal cancer (CRC) screening uptake. The study found no differences in CRC screening uptake for both the personalized provider and patient messages. The findings add to current knowledge around risk messages and CRC screening and require confirmation and extension in subsequent studies, with potential to improve the uptake, effectiveness, and efficiency of CRC screening. The study is published in Annals of Internal Medicine.
Researchers from Indiana University studied data from 214 providers and 1,084 average risk patients across primary care clinics in two health care systems in the Midwest between November 2020 through May 2023. Eligible patients were aged 50 to 75 years, scheduled to see an enrolled provider within a month, and due for CRC screening. Patients were sent a decision aid about CRC screening that included a personalized message about ACN risk (personalized decision aid) or did not (generic decision aid). Providers were also sent a notification that the patient was due for screening that included a personalized message about the patient’s ACN risk (personalized notification) or did not (generic notification). The primary outcome was completion of any screening test within six months of enrollment, and secondary outcomes were completion of each specific screening test (colonoscopy, stool test, and other approved screening tests) within six months. The researchers found that 39.8% of participants completed CRC screening; however, there were no significant effects of the personalized decision aid or the personalized provider notification on uptake of CRC screening.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Peter H. Schwartz, MD, PhD please email phschwar@iu.edu.
----------------------------
2. Report highlights the value of editorial oversight and peer review in clinical trial reporting
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-02250
URL goes live when the embargo lifts
A brief research report evaluated how the quality of abstracts from randomized clinical trial (RCT) reports changes between submission and publication and whether the degree of changes varies according to journal characteristics. The report found that over half of the RCT abstracts examined showed improvement during the peer review and editorial processes, demonstrating the value of editorial oversight. The study is published in Annals of Internal Medicine.
Researchers from the New England Journal of Medicine (NEJM) analyzed abstracts of 496 RCT reports submitted to NEJM in 2022. Rejected articles were searched for in PubMed to determine publication elsewhere within two years of submission. Of the RCTs submitted, 156 were published in NEJM, and 340 were rejected and published in 128 other journals. To assess changes between submitted and published abstracts, the researchers developed the TPAC scoring tool that evaluates improvements across four key domains: trial design, primary outcome, adverse events, and conclusion. They found that 59% of abstracts improved between submission and publication, with conclusions being the most frequently modified domain. Abstracts were more frequently improved in the general medical journals with the highest impact factors. The results support the value of editorial oversight in ensuring research is communicated with accuracy and integrity.
Media contacts: For an embargoed PDF, please contact Gabby Macrina at gmacrina@acponline.org. To contact corresponding author Christos P. Kotanidis, MD, DPhil please email christos.kotanidis@cardiov.ox.ac.uk.
----------------------------
Also new this issue:
The Role of Medical Experts in Transgender Legal Advocacy: A Historical Perspective on Kantaras v. Kantaras
Jason Lee, BA and Jacob D. Moses, PhD
History of Medicine
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-00922
On a Slow Boat to Publication: Rethinking How We Disseminate Medical Research
Kieran L. Quinn, MD, PhD; Christopher M. Booth, MD; Joseph S. Ross, MD, MHS; and Allan S. Detsky, MD, PhD, CM
Ideas and Opinions
Abstract: https://www.acpjournals.org/doi/10.7326/ANNALS-25-02311
Editorial: https://www.acpjournals.org/doi/10.7326/ANNALS-25-03114
END
Personalized risk messages fail to boost colorectal cancer screening participation
2025-09-01
ELSE PRESS RELEASES FROM THIS DATE:
Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid
2025-09-01
In 1951, physicist Julian Schwinger theorized that by applying a uniform electrical field to a vacuum, electron-positron pairs would be spontaneously created out of nothing, through a phenomenon called quantum tunnelling.
The problem with turning the matter-out-of-nowhere theory into Star Trek replicators or transporters? Enormously high electric fields would be required—far beyond the limits of any direct physical experiments.
As a result, the aptly named Schwinger effect has never been seen.
Now theoretical physicists at the University of British Columbia (UBC) have described a parallel effect in a more manageable system. In their model, ...
CRISPR’s efficiency triples with DNA-wrapped nanoparticles
2025-09-01
With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and efficiently into relevant cells and tissues, that promise will remain out of reach.
Now, Northwestern University chemists have unveiled a new type of nanostructure that dramatically improves CRISPR delivery and potentially extends its scope of utility.
Called lipid nanoparticle spherical nucleic acids (LNP-SNAs), these tiny structures carry the full set of CRISPR editing tools — Cas9 enzymes, ...
For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health
2025-09-01
During the dry season in Central America (generally between December and April), northern trade winds generate upwelling events in the ocean waters of the Gulf of Panama. Upwelling is a process that allows cold, nutrient-rich waters from the depths of the ocean to rise to the surface. This dynamic supports highly productive fisheries and helps protect coral reefs from thermal stress. Thanks to this movement of water, the sea along Panama’s Pacific beaches remains cooler during the "summer" vacation season.
Scientists from the Smithsonian Tropical Research Institute (STRI) have studied this phenomenon and their records show that this seasonal upwelling, ...
Depression may make learning to avoid unpleasant events harder
2025-09-01
Depression alters how people pursue rewards, but, conversely, whether depressive symptoms influence how people learn to avoid nonrewarding, unpleasant events is less clear. Ryan Tomm and colleagues, from the University of British Colombia, addressed this question in their eNeuro paper to shed more light on the relationship between depression and learning. This work brought together researchers from preclinical, cognitive, and clinical backgrounds, building stronger connections across fields to better understand the mechanisms of depression.
The researchers developed a behavioral task for study volunteers based off rodent research ...
Study sheds light on how pediatric brain tumors grow
2025-09-01
The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor cells can disrupt normal brain development and function. Current treatments focus mainly on removing the tumor cells, but recent studies have shown that non-cancerous cells, such as nerve cells, also play a role in brain tumor formation and growth, suggesting novel approaches to treating these cancers.
Scientists have long known that a nerve cell signaling chemical called glutamate can increase growth of cancers throughout the body, but despite ...
Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death
2025-09-01
Common shrews are one of only a handful of mammals known to flexibly shrink and regrow their brains. This rare seasonal cycle, known as Dehnel’s phenomenon, has puzzled scientists for decades. How can a brain lose volume and regrow months later without sustaining permanent damage?
A study using non-invasive MRI has scanned the brains of shrews undergoing shrinkage, identifying a key molecule involved in the phenomenon: water.
“Our shrews lost nine percent of their brains during shrinkage, but the cells did not die,” says first author Dr. Cecilia Baldoni, a postdoctoral researcher from the Max Planck Institute of Animal Behavior ...
AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent
2025-09-01
UCLA engineers have developed a wearable, noninvasive brain-computer interface system that utilizes artificial intelligence as a co-pilot to help infer user intent and complete tasks by moving a robotic arm or a computer cursor.
Published in Nature Machine Intelligence, the study shows that the interface demonstrates a new level of performance in noninvasive brain-computer interface, or BCI, systems. This could lead to a range of technologies to help people with limited physical capabilities, such as those with paralysis or neurological conditions, handle and move objects more easily and precisely.
The team developed custom algorithms to decode electroencephalography, or EEG — ...
Black adults face heart failure nearly 14 years earlier than white patients
2025-09-01
Black adults first hospitalized for heart failure in the U.S. at age 60.1, vs. 73.6 for white adults
Hispanic patients first hospitalized at 65.4; Asian American patients at 70.6
CHICAGO --- Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, reports a Northwestern Medicine study that analyzed data from more than 42,000 patients across hundreds of hospitals nationwide.
The study also found that Hispanic patients were hospitalized about eight years earlier than white patients, and Asian patients about three years earlier.
On average, white patients were first hospitalized ...
Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time
2025-09-01
A team of Chilean researchers has identified, for the first time in the country, the presence of KPC-type carbapenemase-producing bacteria in wastewater samples from the Greater Concepción Metropolitan Area. The finding, published in the journal Biological Research, raises concerns about the environmental circulation of microorganisms with high levels of resistance to critical clinically used antibiotics and reinforces the need for surveillance within the framework of "One Health."
The research, which was part of Franco Ilabaca's Master's thesis in Microbiology, was led by Dr. ...
New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke
2025-09-01
Conference: “Late Breaking Science” presentation at the European Society of Cardiology - AI driven cardiovascular biomarkers and clinical decisions
Title: Graph Neural Network Automation of Anticoagulation Decision-Making
Date: Embargo lifts Monday, September 1, 4:00 pm EDT
Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide whether or not to treat them with anticoagulants (blood thinner medications) to prevent stroke, which is currently the standard treatment course in this patient population. This model presents a completely ...